AR vs REGN · P/E 12, rev $4.33B vs P/E 14, rev $14.34B
Antero Resources Corp (AR) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Antero Resources Corp (AR) is a oil & gas e&p company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AR revenue for 2024-12-31 was $4.33B. Net income was $93.7M. Revenue was down 7.6% from 2023-12-31 to 2024-12-31. AR currently screens at market cap $11.08B and trailing P/E 11.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AR currently screens at market cap $11.08B and trailing P/E 11.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AR and REGN stock pages for the full models.
Not investment advice.